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VALORIZATION 
 
SOCIAL RELEVANCE 
Obesity is a worldwide increasing problem, warranting for new prevention and 
treatment strategies to reduce the risk on developing chronic diseases related to 
excess body weight. According to the 2016 report of the World Health Organization 
(WHO) the prevalence of obesity is still increasing worldwide, with 39% of adults aged 
18 years and older being overweight (> 1.9 billion adults) and 13% being obese (>600 
million adults) (1). It is especially alarming that 41 million children under the age of 5, 
and 340 million children and adolescents aged 5-19 were overweight and obese in 
2016 (1). Overweight and obesity are major risk factors for the development of type 2 
diabetes mellitus (T2DM). Just like obesity, the prevalence of T2DM has been steadily 
increasing over the past few decades. T2DM is associated with various comorbidities, 
including cardiovascular diseases and non-alcoholic fatty liver disease as well as an 
increased mortality risk. The WHO underscores in their global report on diabetes the 
enormous scale of the diabetes problem, and also the potential to reverse current 
trends (2). It has also been pointed out by the WHO that obesity is preventable (1). 
Furthermore, T2DM is one of the four priority noncommunicable diseases (NCDs) 
targeted by world leaders in the 2011 Political Declaration on the Prevention and 
Control of NCDs (2). These reports and declarations highlight the importance of the 
prevention and treatment of obesity and T2DM worldwide. 
 
The fundamental causes of obesity and T2DM include a high caloric diet and 
insufficient physical activity. Effective tools are available to prevent obesity and T2DM 
and to improve disease management to reduce the risk of complications. Promoting 
physical activity is considered one of the most potent strategies to prevent and treat 
T2DM. World leaders agreed that one of the global targets for the prevention of T2DM 
(and other NCDs) to be attained by 2025 is a 10% relative reduction in the prevalence 
of insufficient physical activity (2). Other effective strategies for the prevention and 
treatment of obesity and T2DM include a healthy diet low in calories. Existing 
strategies that stimulate physical activity and promote a healthy diet are effective in 
reducing body weight and improving glucose homeostasis in patients with obesity 
and T2DM. However, these strategies seem to be challenging to adhere to on the 
long term for the people at risk. Therefore, it is important to investigate other strategies 
to prevent and treat obesity and T2DM. The present thesis describes three novel 
approaches that could lead to novel prevention and treatment strategies for people 
with obesity and obesity-related comorbidities such as T2DM and cardiovascular 
diseases. 
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Supplementation with the NAD+ precursor nicotinamide riboside has been 
investigated in this thesis as the first novel approach. Nicotinamide riboside can be 
easily added to the normal diet, which would enhance the compliance for the general 
public in contrast to low compliance rates for exercise training or a rigorous diet. 
Although it has been shown that nicotinamide riboside had many metabolic benefits 
including improvements in insulin sensitivity in animal models, these effects could so 
far not be translated to humans, as also shown in this thesis. However, since a relative 
short intervention period was applied in this thesis, future research should investigate 
whether long term supplementation with nicotinamide riboside could have metabolic 
benefits in humans to prevent or treat obesity and T2DM. The second novel approach 
that was investigated in this thesis was non-shivering cold acclimation. From this 
thesis we conclude that non-shivering cold acclimation for ten days at 16-17 °C does 
not have major beneficial health effects in humans with T2DM. However, it could be 
suggested that mild shivering induced by cold environmental temperatures, either 
indoor or outdoor, could be a novel way to improve metabolic health for the general 
public. More research is needed to quantify the amount and intensity of shivering that 
is needed to contribute to the prevention and treatment of obesity and T2DM, and the 
practical applicability in daily life. As a third novel approach we investigated whether 
replacing sitting time with low-intensity physical activities would have the same 
metabolic benefits compared to replacing sitting time with a single moderate-to-
vigorous exercise bout per day. In this thesis we demonstrated that low-intensity 
physical activities such as standing and walking are similar effective in improving 
insulin sensitivity compared to a single moderate-to-vigorous exercise bout per day. 
Taken together, investigating novel approaches that have beneficial health effects 
and that can be implemented in daily life are of great social relevance to prevent and 
treat obesity, T2DM and other metabolic diseases. 
 
ECONOMIC RELEVANCE 
Obesity, T2DM and related comorbidities are a major economic burden for national 
health care systems, as well as for the patients and their families. In the Netherlands, 
total health care costs for T2DM (including comorbidities) were 1.6 billion euro’s in 
2017 (3). Preventing obesity and T2DM via inexpensive and easy to access strategies 
such as the ones presented in this thesis can contribute to a reduction in global 
economic burden. Increasing physical activity by standing and walking is not only 
freely accessible and inexpensive for the general public, it does also contribute to a 
reduction in transportation use and costs. Food supplements, such as nicotinamide 
riboside, can be an inexpensive and easy addition to a healthy diet. Furthermore, 
lowering indoor temperatures and thereby challenging the body to deal with cooler 
environments, cannot only could improve human health but can also could reduce 
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heating costs of homes, offices and buildings. Above all, a reduction in transportation 
and heating contributes to less emission of greenhouse gasses. Scientific evidence 
exists that warming of the climate system is unequivocal and that greenhouse gasses 
emitted by human activities are the primary driver (4). The Paris Agreement signed in 
2016 by 195 countries, states that by 2050 the emission of greenhouse gasses has to 
be reduced by 95% in comparison to the level in 1990 (5, 6). As obesity and T2DM is 
an increasing problem and at the same time climate change is an urgent matter, the 
investigation of novel health promoting strategies to prevent and treat obesity and 
T2DM that are at the same time climate-friendly are of great economic relevance. 
 
ACTIVITIES AND PRODUCTS 
All studies described within this thesis were executed at the Department of Nutrition 
and Movement Sciences at Maastricht University within the Diabetes and Metabolism 
Research Group. The Diabetes and Metabolism Research Group investigates the 
mechanisms underlying the pathogenesis of T2DM and related metabolic diseases 
by performing translational research. The studies presented in this thesis were 
performed in close collaboration with the Department of Radiology and Nuclear 
Medicine of Maastricht University Medical Centre. This collaboration between 
scientists and the clinic allowed us to use non-invasive techniques like MR and a PET-
CT scanning. Furthermore, research presented in this thesis is part of a large 
consortium (CVON ENERGISE 2014-02) between Amsterdam Medical Center, Leiden 
University Medical Center, Wageningen University and Maastricht University. Being 
part of such a consortium enhances collaborations between the different centers and 
thereby improves translational research. 
 
The results presented in this thesis are or will be published in original scientific articles 
in international well-recognized peer-reviewed journals. Importantly, articles will be 
available online and can be assessed by scientists or other interested people 
worldwide. Furthermore, results from the studies described in this thesis are 
communicated and presented to the scientific community on (inter)national 
conferences and symposia via oral presentations and posters. Via this way, research 
knowledge was spread within the scientific community to facilitate new research ideas 
and hypotheses and to promote future research. 
 
INNOVATION 
The study results presented in this thesis are obtained in humans by state-of-the-art 
methods and techniques. When human clinical trials are performed, it is of great 
importance that reliable results are obtained in the most non-invasive way possible. 
In this thesis, we applied relatively new MRS techniques developed by our research 
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group to examine among others lipid accumulation in the muscle and muscle 
acetylcarnitine dynamics in a non-invasive way. In the past, these outcomes could 
only be studied and quantified with the use of tissue biopsies. Furthermore, we used 
stable isotope tracers during the hyperinsulinemic-euglycemic clamps and during the 
assessment of brown adipose tissue activity in combination with PET scanning. We 
also used a metabolic chamber to assess sleeping metabolic rate upon NR 
supplementation and to control the indoor environment with a stable temperature 
during the cold acclimation study period. Collaborations within the ENERGISE 
consortium allowed us to use additional technologies, such as metabolomics, to 
obtain more results from the valuable muscle tissue samples. The combination of 
these advanced techniques can only be performed in a few research departments 
worldwide and leads to innovative translational research data. 
 
Furthermore, many research has been performed on classic intervention strategies 
such as exercise training (endurance training, resistance training, high intensity 
interval training or a combination) and reducing caloric intake with various diets (such 
as low carbohydrate diet, high protein diet, low fat diet, low glycemic load diet, 
Mediterranean diet, paleo diet, intermittent fasting or a combination). These 
intervention strategies share a common goal: increasing energy expenditure and 
reducing energy intake resulting in a low cellular energy status. A low cellular energy 
status activates metabolic pathways that lead to metabolic adaptations which are 
favorable for human health, such as an increase in insulin sensitivity. The research 
presented in this thesis describes the investigation of novel approaches to improve 
insulin sensitivity by targeting the same metabolic pathways as are activated by 
exercise training and caloric restriction, but then with novel strategies: 
supplementation with the food supplement nicotinamide riboside, non-shivering cold 
acclimation, and replacing sitting time by low-intensity physical activities. 
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